Liu J, Chen J, Sun J, Yao L, Zhang J, Xie Y*, Xu Y*: Low Expression of PALB2 is Associated With Poor Survival in Chinese Women With Primary Breast Cancer.,Clin Breast Cancer,2023,23:e259-e266

Wan Q#, Hu L#, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xu Y*, Xie Y*.Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer.,Fam Cancer,2021,20:85-95

Sheng S#, Xu Y#, Guo Y, Yao L, Hu L, Ouyang T, Li J, Wang T, Fan Z, Fan T, et al: Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer,Int J Cancer,2020,146:487-495

Su L#, Xu Y#, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y: Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients,Int J Cancer,2019,146:3335-3342

Wu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xu Y*, Xie Y*: Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.,Breast Cancer Res Treat,2020,179:605-614

家族遗传性乳腺癌发病机制研究

乳腺癌个体化治疗

乳腺癌易感基因PALB2致瘤分子机制及其与PARP抑制剂敏感性的研究, 课题负责人, 2021.1.1～2024.12.31, 国家自然科学基金委员会, 面上项目

BRCA1/2突变三阴性乳腺癌对蒽环类药物耐药机制研究, 参加者, 2018.1.1～2021.12.31, 国家自然科学基金委员会, 面上项目